Saturday , January 20 2018
Home / Letter From The Editor (page 87)

Letter From The Editor

Editor’s Note: Bydureon Update

I had hoped that this week’s Clinical Mastery edition would have included information from the Duration Trials for the once weekly form of exenatide, Bydureon. Many of us had been anticipating approval of this revolutionary treatment for diabetes, and were anxious to have this new treatment option for our patients. …

Read More »

Letter from the Editor: EASD Report

The EASD (European Association for the Study of Diabetes) just finished their 46th Annual Meeting and there was a lot of great information. This issue will condense and review for you the most exciting and new information that was presented at the meeting. Learn how diagnosing diabetes early and treating …

Read More »

Letter from the Editor: New Healthcare Rules

Some new healthcare rules took effect last week offering a measure of safety and security for our diabetes patients. As part of the healthcare reform act of 2010, adult children can stay on their parents’ insurance through age 26, they cannot be dropped for pre-existing conditions and their insurance cannot …

Read More »